NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 308 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $759 | -61.1% | 47 | 0.0% | 0.00% | – |
Q2 2023 | $1,951 | -77.9% | 47 | -68.0% | 0.00% | – |
Q1 2023 | $8,841 | -19.6% | 147 | -2.0% | 0.00% | -100.0% |
Q4 2022 | $11,003 | +10.0% | 150 | +2.7% | 0.00% | 0.0% |
Q3 2022 | $10,000 | 0.0% | 146 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $10,000 | -9.1% | 146 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $11,000 | -83.6% | 146 | -74.8% | 0.00% | -50.0% |
Q3 2021 | $67,000 | -44.6% | 580 | +6.0% | 0.00% | -50.0% |
Q2 2021 | $121,000 | +95.2% | 547 | +17.1% | 0.00% | +100.0% |
Q1 2021 | $62,000 | – | 467 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |